Telix Pharmaceuticals Limited (ASX:TLX) FDA Accepts BLA for TLX250-CDx
Telix Pharmaceuticals (ASX:TLX) announces FDA acceptance of BLA for TLX250-CDx, targeting kidney cancer imaging with a planned U.S. launch in 2025.

Telix Pharmaceuticals (ASX:TLX) announces FDA acceptance of BLA for TLX250-CDx, targeting kidney cancer imaging with a planned U.S. launch in 2025.
EDU Holdings Limited (ASX:EDU) reports a 96% revenue increase in FY24, achieving a net profit of $2.6m and significant operational growth.
Power Minerals Limited (ASX:PNN) expands its Rincon Lithium Project through a strategic MOU, acquiring the Pocitos Project and divesting the Santa Ines Copper-Gold Project.
RPM Automotive Group Limited (ASX:RPM) reports H1 FY25 results, highlighting revenue growth and strategic initiatives for future expansion.
Kelsian Group Limited (ASX:KLS) reports FY25 half-year results in line with expectations and introduces a new capital management framework.
Lynas Rare Earths Ltd (ASX:LYC) reports an 8% revenue increase in H1 2024, alongside key operational milestones and strong safety performance.
dusk Group Limited (ASX:DSK) reports a 12.3% sales increase in 1H FY25 and declares a 10c per share dividend.
BlueBet Holdings Ltd (ASX:BBT) offers $340-$360M to acquire PointsBet, aiming to realise $40M in annual synergies.
Woolworths Group (ASX:WOW) reports a 3.7% sales increase in H1, a 14.2% EBIT decline, and a revised interim dividend of 39c.
Bell Financial Group Ltd (ASX:BFG) announces it will not counter Selfwealth’s acquisition proposal, citing valuation and market conditions.